Skip to main content

Highlights

  1. 1
    Dementia and geriatric cognitive disorders · 2021
    PMID: 34058741PMCID: PMC8376803DOISenior author9 citations
  2. 2
    Frontiers in molecular biosciences · 2025
    PMID: 40438709PMCID: PMC12116374DOIFirst author7 citations
  3. 3
    Scientific reports · 2025
    PMID: 41392163PMCID: PMC12804985DOIeCommonsFirst author1 citations

Publications

47 publications

Active

2 grants
  • MPI
    Development of An Integrated Pipeline for Early PD Prediction and Disease Modifying Drug Repurposing
    National Institute of Neurological Disorders and Stroke · 2026–2031
    R01NS148533-01
  • PI
    Understanding Sex-Specific Mechanisms of Amygdala dysfunction to Advance Tailored Therapies in PD
    Michael J. Fox Foundation for Parkinson's Research · 2026–2028
    MJFF-028026
Completed grants (9)
  • Co-I
    ASAP - Aligning Science Across Parkinson's
    Michael J. Fox Foundation for Parkinson's Research · 2021–2025
    MJF 214365-03
  • Co-I
    Gene therapy to address unmet needs in Parkinson's Disease
    JPB Foundation, The · 2021–2024
    JPB 226700-01
  • PI
    Peri-menopause as a neurological transition state that triggers Alzheimer's disease onset and accelerates disease progression
    National Institute on Aging · 2020–2023· 3 renewals
    R21AG064455-02
  • Co-I
    Gene therapy to address unmet needs in Parkinson's disease
    JPB Foundation, The · 2018–2021
    JPBF 184517-01
  • Co-I
    LRRK2 Activity and Dyskinesia
    Michael J. Fox Foundation for Parkinson's Research · 2019–2020
    MJFF 194725-01
  • PI
    Menopause as an Important transition State in the Susceptibility to Parkinson's Disease
    American Parkinson Disease Association · 2018–2020
    APDA 190167-01
  • KP
    Gene Therapy for Motor and Non-Motor Symptoms of Parkinson's Disease
    JPB Foundation, The · 2015–2018
    469
  • Co-I
    Supplement Role of LRRK2 in Levodopa-Induced Dyskinesia
    Michael J. Fox Foundation for Parkinson's Research · 2017–2018
    11601.01
  • KP
    XIAP Gene Therapy for Huntington's Disease
    National Institute of Neurological Disorders and Stroke · 2010–2014
    R01NS067414-04 EW

News mentions

  • $9M Grant Funds Study of Gut-Brain Connection in Parkinson’s Disease
    October 26, 2021

    Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies for movement disorders, leads a team that has been awarded a three-year, $8.9 million grant from the Aligning Science Across Parkinson’s (ASAP) initiative.